Urothelial carcinoma | Intravesical recurrence | Upper tract recurrence | ||||
---|---|---|---|---|---|---|
HR(95% CI) | P value | HR(95% CI) | P value | HR(95% CI) | P value | |
Smoke | 0.058 | 0.695 | 0.312 | |||
No | Reference | Reference | Reference | |||
Yes | 1.416 (0.988–2.029) | 0.993 (0.657–1.323) | 1.298 (0.783–2.154) | |||
Gender | 0.102 | 0.540 | 0.084 | |||
Female | Reference | Reference | Reference | |||
Male | 0.754 (0.537–1.058) | 1.121 (0.778–1.616) | 0.660 (0.412–1.057) | |||
Previous malignancy | 0.151 | 0.013* | 0.013* | |||
Non-HPM | Reference | Reference | Reference | |||
Uro-HPM | 1.408 (0.985–2.014) | 0.061 | 0.981 (0.641–1.502) | 0.931 | 1.938 (1.214–3.095) | 0.006** |
Non-uro-HPM | 1.229 (0.794–1.901) | 0.355 | 1.810 (1.206–2.719) | 0.004** | 0.874 (0.430–1.777) | 0.710 |
pT Stage | 0.012* | 0.760 | 0.139 | |||
Ta/Tis/T1 | Reference | Reference | Reference | |||
T2-4 | 1.598 (1.111-2.300) | 1.059 (0.732–1.534) | 0.668 (0.391–1.140) | |||
Tumor Grade | 0.419 | 0.537 | 0.013* | |||
G1-2 | Reference | Reference | Reference | |||
G3 | 0.867 (0.613–1.226) | 0.891 (0.617–1.286) | 1.916 (1.145–3.204) |